Award
NIH Reporter #5R01HS029501-04
Deprescribing of Disease Modifying Agents in Older Adults with Multiple Sclerosis
Recipient
University of Houston, Houston, TX
Award Amount
$397,090.00
Ceiling
$397,090.00
Awarded
April 21, 2026
Identifier
5R01HS029501-04
This NIH grant funds research on the effects of stopping DMAs in older adults with MS, focusing on relapse rates, frailty, infections, and mortality.
Description
Study to evaluate the safety and effectiveness of discontinuing Disease Modifying Agents (DMAs) in older adults with multiple sclerosis (MS) using a longitudinal national cohort and Medicare claims data.